1. A10 SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. (16th November 2010) Authors: Taylor, D; Pallos, J; Lambert, E; Amore, A; Parker, A; Moffitt, H; Smith, D; Runne, H; Gokce, O; Kuhn, A; Xiang, Z; Maxwell, M; Reeves, S; Bates, G; Néri, C; Thompson, L; Marsh, L; Kazantsev, A; Luthi-Carter, R Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 81(2010)Supplement 1 Page Start: A3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A17 Myeloid cell function in mouse models of Huntington's disease. (16th November 2010) Authors: André, R; Schure, U; Magnusson, A; Lahiri, N; Smith, D; Lowdell, M W; Bates, G; Bjorkqvist, M; Tabrizi, S J Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 81(2010)Supplement 1 Page Start: A5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A4 Development of disease modifying therapies in Huntington's disease. Issue 10 (7th September 2012) Authors: Bates, G Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 83:Issue 10(2012) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Atomoxetine-induced electrocardiogram changes. Issue 12 (21st November 2006) Authors: Rajesh, A S; Bates, G; Wright, J G C Journal: Archives of disease in childhood Issue: Volume 91:Issue 12(2006) Page Start: 1023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. B09 Caspase-6 does not contribute to the proteolysis of mutant huntingtin in the HDHQ150 knock-in mouse model of Huntington's disease. (29th August 2012) Authors: Landles, C; Smith, D; Weiss, A; Franklin, S; Howland, D; Bates, G Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 83(2012)Supplement 1 Page Start: A8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. B23 Immune dysfunction in HD human myeloid cells is caused by NFκB pathway dysregulation and is reversed by lowering HTT levels. (29th August 2012) Authors: Träger, U; André, R; Lahiri, N; Magnusson, A; Pfister, E; Weiss, A; Grüninger, S; Antoniou, M; Bates, G; Muchowski, P; Björkqvist, M; Ostroff, G; Aronin, N; Tabrizi, SJ Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 83(2012)Supplement 1 Page Start: A12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Detection and measurement of fetomaternal haemorrhage: serum alpha-fetoprotein and the Kleihauer technique. Issue 6073 (28th May 1977) Authors: Lachman, E; Hingley, S M; Bates, G; Ward, A M; Stewart, C R; Duncan, S L Journal: BMJ Issue: Volume 1:Issue 6073(1977) Page Start: 1377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. F05 Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression. (29th August 2012) Authors: Andre, R; Weiss, A; Träger, U; Grueninger, S; Farmer, R; Landles, C; Scahill, R; Lahiri, N; Haider, S; Macdonald, D; Frost, C; Bates, G; Bilbe, G; Kuhn, R; Wild, E; Tabrizi, SJ Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 83(2012)Supplement 1 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗